August 10 2018 - FDA approves first RNA interference drug

FDA approves first RNA interference drug
Gemphire’s lead drug worsens disease, trial ends
Generic drugmakers struggle despite push for copycats
Astellas buys out biotech for glaucoma gene therapy program
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com